Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
You searched for:
Health Insurance and Insights from Health Literacy: Helping ...
Released: March 13, 2017
The Roundtable on Health Literacy of the National Academies of Sciences, Engineering, and Medicine convened a public workshop to examine health insurance through the lens of health literacy, focusing on literacy related barriers to information and coverage as well as on possible solutions.
Therapeutic Development in the Absence of Predictive Animal ...
Released: March 10, 2017
Despite the high prevalence and burden of nervous system disorders, development of new therapeutics lags behind other disease areas. Gaps in understanding the underlying pathophysiology, a dearth of biomarkers, and limitations in the capacity of animal models to predict drug efficacy for human brain disorders have contributed to a high rate of late stage failures in drug development and decreased investment in neuroscience research programs at pharmaceutical companies. On September 12-13, 2016, the National Academies of Sciences, Engineering, and Medicine’s Forum on Neuroscience and Nervous System Disorders hosted a public workshop to explore opportunities to accelerate drug development absent predictive animal models.
Countering Violent Extremism Through Public Health Practice ...
Released: February 17, 2017
Countering violent extremism (CVE) consists of various prevention and intervention approaches to increase the resilience of communities and individuals to radicalization toward violent extremism, to provide nonviolent avenues for expressing grievances, and to educate communities about the threat of recruitment and radicalization to violence.
Real-World Evidence Generation and Evaluation of ...
Released: February 15, 2017
The traditional process for evaluating new therapeutics does not produce the evidence that patients, clinicians, and payers need for real-world decisions. The volume and complexity of information about individual patients is greatly increasing with use of electronic records and personal devices. Potential effects on medical product development in the context of this wealth of real-world data are numerous and varied, ranging from the ability to determine both large-scale and patient-specific effects of treatments to assessing how therapeutics affect patients’ lives through measurement of lifestyle changes.
Integration of FDA and NIOSH Processes Used to Evaluate ...
Released: February 01, 2017
The Food and Drug Administration (FDA) and the National Institute for Occupational Safety and Health (NIOSH) have responsibilities for evaluating and regulating respiratory protective devices (RPDs) for health care workers. To provide input to NIOSH and FDA and to discuss potential next steps to integrate the two agencies’ processes to certify and approve N95 respirators for use in health care settings, a workshop was held by the National Academies of Sciences, Engineering, and Medicine (the National Academies).
Community Violence as a Population Health Issue ...
Released: January 17, 2017
On June 16, 2016, the Roundtable on Population Health Improvement held a workshop in Brooklyn, New York, to explore the influence of trauma and violence on communities. The workshop was designed to bring attention to the impact of racism and violence on communities; some social and physical interventions that can change landscapes of violence; some local strategies to build community resilience and safety; some lessons learned from select approaches and initiatives designed to reduce community violence, and public health-informed approaches to community policing and collaboration. This Proceedings of a Workshop synthesizes the presentations and discussions that occurred during the workshop, Community Violence as a Population Health Issue.
Exploring Strategies to Improve Cardiac Arrest Survival ...
Released: December 20, 2016
Cardiac arrest often strikes seemingly healthy individuals without warning and without regard to age, gender, race, or health status. Following the release of the 2015 Institute of Medicine (IOM) consensus report, Strategies to Improve Cardiac Arrest Survival: A Time to Act, eight sponsors asked the Health and Medicine Division to hold a workshop to assemble diverse stakeholders who would explore the barriers and opportunities for advancing the IOM recommendations.
Big Data and Analytics for Infectious Disease Research ...
Released: December 08, 2016
With the amount of data in the world exploding, big data could generate significant value in the field of infectious disease. The Forum on Microbial Threats determined that the broader applications and implications of big data in these areas ought to be explored, where “big data” refers to any voluminous amount of structured, semi-structured, and unstructured data that has the potential to be mined for insights and information.
The Ebola Epidemic in West Africa: Proceedings of a ...
Released: December 06, 2016
The most recent Ebola epidemic that began in late 2013 alerted the entire world to the gaps in infectious disease emergency preparedness and response. Building on previous outbreak workshops, the Forum on Microbial Threats convened this workshop to understand the recent developments in incidence, prevalence, and intervention strategies used to mitigate the disease in an increasingly interconnected world. Recognizing the opportunity to learn from the countless lessons of this epidemic, this workshop discussed the challenges to successful outbreak responses at the scientific, clinical, and global health levels.
Enhancing BioWatch Capabilities Through Technology and ...
Released: December 05, 2016
In response to the 2015 Government Accountability Office (GAO) report Biosurveillance: DHS Should Not Pursue BioWatch Upgrades or Enhancements Until System Capabilities Are Established, the Department of Homeland Security (DHS) requested that the National Academies of Sciences, Engineering, and Medicine conduct a workshop to further explore the findings of the 2015 GAO report and discuss the impact these findings may have with regard to the future development of the technical capabilities of the BioWatch program.